porcin
aminopeptidas
n
papn
cellular
receptor
transmiss
gastroenter
viru
tgev
porcin
coronaviru
interact
spike
protein
tgev
papn
initi
cell
infect
small
molecul
especi
peptid
expand
area
therapi
diagnost
assay
viral
diseas
peptid
capabl
bind
papn
first
time
identifi
biopan
use
random
peptid
librari
immobil
protein
three
chemic
synthes
peptid
recogn
papn
show
effect
inhibit
abil
tgev
infect
vitro
put
txxf
motif
identifi
protein
tgev
phage
bear
specif
peptid
interact
papn
elisa
tetrazolium
bromid
mtt
assay
confirm
protect
effect
peptid
cell
infect
tgev
moreov
excel
immun
respons
mice
induc
identifi
phage
provid
possibl
develop
novel
phagebas
vaccin
transmiss
gastroenter
viru
tgev
caus
agent
transmiss
gastroenter
tge
highli
contagi
enter
diseas
swine
typic
clinic
symptom
tge
consist
vomit
acut
diarrhea
dehydr
older
anim
usual
recov
newborn
piglet
mortal
rate
may
reach
saif
wesley
laud
et
al
schwegmannwessel
et
al
ren
et
al
tge
preval
caus
enorm
econom
loss
pig
industri
tgev
envelop
singlestrand
positivesens
rna
viru
belong
famili
coronavirida
order
nidoviral
yin
et
al
largest
rna
viral
genom
kb
tgev
produc
least
eight
subgenom
mrna
viral
replic
mrna
consist
cotermin
nest
set
laud
et
al
vaughn
et
al
three
major
structur
protein
coronaviru
spike
integr
membran
glycoprotein
nucleocapsid
n
protein
translat
mrna
respect
spaan
et
al
laud
et
al
et
al
protein
abund
compon
coronavirus
rottier
ren
et
al
protein
major
interferon
induc
compon
propos
play
role
innat
immun
respons
coronavirus
charley
laud
laud
et
al
roughli
onethird
tgev
protein
assum
topolog
part
endodomain
constitut
fourth
transmembran
segment
therebi
posit
carboxi
terminu
molecul
exterior
virion
master
risco
et
al
tgev
n
phosphoprotein
complex
genom
rna
beadsonastr
fashion
form
nucleocapsid
et
al
cavanagh
et
al
protein
coronavirus
larg
transmembran
protein
amino
terminu
expos
viru
surfac
carboxi
terminu
insid
viru
particl
assembl
trimer
form
distinct
viral
surfac
spike
coronaviru
protein
play
import
role
induc
neutral
antibodi
garw
et
al
et
al
laud
et
al
et
al
also
relat
host
cell
tropism
jacob
et
al
schwegmannwessel
et
al
ren
et
al
pathogen
siddel
krempl
et
al
fusion
collin
et
al
spaan
et
al
hemagglutin
activ
krempl
et
al
krempl
herrler
interact
cellular
receptor
porcin
aminopeptidas
n
papn
delma
et
al
liu
et
al
ren
et
al
apn
also
call
human
type
ii
transmembran
ectopeptidas
kda
contain
zincbind
motif
heiah
form
noncoval
bound
homodim
cellular
membran
liu
et
al
apn
extens
express
variou
cell
line
hematopoiet
cell
myeloid
origin
fibroblast
brain
cell
epitheli
cell
liver
kidney
intestin
etc
tsukamoto
et
al
zhang
et
al
report
aminopeptidas
n
papn
cellular
receptor
group
coronavirus
includ
human
coronaviru
tgev
felin
coronaviru
fcov
canin
coronaviru
ccov
delma
et
al
tresnan
et
al
yeager
et
al
gener
apn
receptor
mani
coronavirus
speciesspecif
kolb
et
al
although
felin
apn
fapn
also
serv
receptor
canin
coronaviru
tgev
human
coronaviru
addit
felin
infecti
periton
viru
tresnan
et
al
papn
consist
sever
identifi
region
includ
initi
methionin
cytoplasm
topolog
domain
transmembran
region
cytosol
serthrrich
junction
region
metalloproteas
region
tgev
spike
glycoproteininteract
region
respect
fig
peptid
ligand
target
specif
protein
surfac
broad
applic
therapeut
interf
proteinprotein
interact
phage
display
librari
provid
power
inexpens
way
identifi
peptid
phage
random
peptid
librari
consist
pool
billion
peptid
produc
fusion
random
nucleic
acid
sequenc
n
terminu
one
capsid
protein
gene
pviii
piii
filament
bacteriophag
cwirla
et
al
devlin
et
al
scott
smith
optim
biopan
singl
clone
phage
desir
bind
specif
random
phage
librari
identifi
approach
appli
success
numer
aspect
includ
antibodi
engin
hayden
et
al
peptid
protein
drug
discoveri
manufactur
kay
et
al
diagnost
analysi
ren
et
al
vaccin
develop
lesinski
westerink
present
precis
local
receptorbind
domain
rbd
tgev
protein
remain
unclear
time
rbdcontain
peptid
may
use
small
molecul
diagnosi
therapi
viral
infect
studi
identifi
first
time
specif
peptid
recogn
papn
block
bind
tgev
base
phage
display
technolog
peptid
competit
block
tgev
infect
vitro
therefor
use
specif
antivir
inhibitor
put
txxf
motif
identifi
protein
moreov
peptidecontain
phage
elicit
effect
immun
respons
vivo
demonstr
potenti
perspect
develop
phagebas
vaccin
gene
encod
truncat
papn
delet
cytoplasm
topolog
domain
transmembran
region
fig
amplifi
use
pcr
clone
vector
authent
recombin
plasmid
petapn
confirm
dna
sequenc
papnbear
bacteria
induc
iptg
express
protein
interest
petapn
transform
host
bacteria
sdspage
indic
fusion
protein
kda
immunoreact
protein
confirm
western
blot
immunofluoresc
data
shown
four
round
biopan
use
papnprotein
immobil
target
enrich
efficaci
phage
round
analyz
titer
phage
elut
buffer
amplifi
phage
increas
increas
pan
time
tabl
ten
phage
clone
number
pick
last
round
pan
amplifi
host
cell
bind
activ
select
phage
target
protein
assay
use
elisa
result
show
specif
bind
activ
papn
fig
dna
phage
extract
heterolog
gene
encod
peptid
surfac
recombin
phage
amplifi
primerspecif
pcr
dna
sequenc
report
show
three
ident
peptid
identifi
among
ten
phage
tabl
phage
number
consensu
peptid
sequenc
svvpskatwgfa
name
phage
consensu
sequenc
hvtttfappppr
name
h
consensu
sequenc
deriv
phage
fkpssppsitlw
name
f
result
show
three
peptid
sequenc
homolog
txxf
ak
pxxp
overlap
motif
could
identifi
identifi
motif
compar
tgev
protein
sequenc
sever
txxf
motif
identifi
protein
supplementari
fig
elisa
result
show
three
peptid
capabl
bind
papn
tgev
coat
plate
higher
bind
activ
peptid
signific
bind
ibv
protein
antipapn
antibodi
fig
viru
infect
inhibit
assay
show
st
cell
infect
tgev
produc
signific
cytopath
effect
cpe
h
post
infect
contrast
cpe
number
peptidetr
st
cell
infect
tgev
decreas
dosedepend
manner
maximum
inhibitori
activ
tgev
infect
vitro
achiev
concentr
peptid
fig
convent
mtt
assay
use
analyz
effect
peptid
prolifer
st
cell
infect
tgev
result
show
od
valu
peptidetr
st
cell
infect
tgev
higher
viru
infect
control
indic
prolifer
cell
infect
tgev
enhanc
peptid
fig
pretreat
peptid
led
increas
number
viabl
cell
also
confirm
antivir
abil
biolog
activ
peptid
phage
bear
identifi
peptid
use
immun
mice
indic
time
point
antibodi
peripher
blood
immun
mice
use
primari
antibodi
detect
tgev
elisa
result
show
peptid
display
filament
phage
trigger
immun
respons
mice
tge
virion
papnrecogn
peptid
elicit
stronger
humor
immun
respons
control
phage
bear
complex
peptid
although
control
serum
might
also
react
tge
virion
certain
extent
fig
number
lymphocyt
peripher
blood
spleen
immun
mice
quantifi
flow
cytometri
number
cell
increas
day
postimmun
mice
immun
phage
compar
mockimmun
mice
day
postimmun
differ
cell
number
immun
group
control
becam
signific
fig
apn
serv
cellular
receptor
sever
coronavirus
studi
aim
use
protein
target
protein
identifi
ligand
investig
role
small
molecul
prokaryot
system
optim
choic
achiev
highlevel
express
heterolog
protein
yin
et
al
previou
studi
express
protein
escherichia
coli
clone
gene
differ
vector
pgex
liu
et
al
fuse
protein
glutathionestransferas
gst
tag
high
molecular
weight
kda
might
crossreact
unrel
protein
therefor
clone
truncat
papn
gene
anoth
prokaryot
vector
own
lac
promot
small
tag
histidin
protein
rosetta
host
strain
use
studi
design
enhanc
express
eukaryot
protein
contain
rare
codon
suppli
trna
agg
aga
aua
cua
ccc
gga
codon
compat
chloramphenicolresist
plasmid
name
prare
make
rosetta
strain
univers
translat
translat
would
otherwis
limit
codon
usag
e
coli
novi
et
al
mani
heterolog
protein
express
system
li
et
al
b
meng
et
al
ren
et
al
studi
high
level
express
papn
achiev
express
system
papn
glycoprotein
biolog
activ
main
concern
due
inabl
modif
posttransl
e
coli
previous
gener
antipapn
antibodi
deriv
rabbit
immun
pgexpapn
studi
bacteri
express
petapn
protein
detect
western
blot
use
antipapn
antibodi
time
confirm
antibodi
petapn
protein
react
transient
express
papn
eukaryot
cell
immunofluoresc
assay
preincub
antibodi
cell
significantli
decreas
cell
infect
tgev
data
shown
taken
togeth
data
indic
papn
use
studi
biolog
activ
interestingli
express
papn
achiev
transmembran
domain
locat
nterminu
delet
hydrophil
antigen
index
analyz
use
dnastar
softwar
result
show
first
amino
acid
n
terminu
papn
strong
hydrophil
region
low
antigen
index
data
shown
result
suggest
transmembran
domain
papn
may
affect
subsequ
translat
papn
e
coli
applic
vaccin
still
major
prevent
measur
tgev
infect
although
papn
identifi
cellular
receptor
tgev
delma
et
al
import
effect
peptid
drug
discoveri
notic
due
appar
abil
home
activ
biolog
site
target
protein
yi
et
al
found
phagedisplay
peptid
select
combinatori
librari
interact
viral
protein
receptor
capabl
block
infect
hepat
b
viru
tabl
titrat
phage
postpan
first
second
third
fourth
elut
amplif
na
phage
densiti
pfuml
incub
papn
protein
round
pan
titer
phage
elut
buffer
elut
amplif
host
cell
calcul
shown
phage
select
elut
fourth
round
pan
phage
titer
time
measur
na
bind
select
phage
papn
elisa
ten
select
phage
number
unrelev
phage
number
incub
coat
papn
bovin
serum
albumin
control
uncoat
elisa
plate
follow
success
incub
antibodi
hrpconjug
secondari
antibodi
od
valu
individu
phage
three
parallel
well
shown
axi
number
phage
shown
x
axi
h
v
tt
f
p
p
p
p
r
h
f
k
p
p
p
l
w
f
ten
select
phage
phage
subject
dna
extract
pcr
deduc
amino
acid
sequenc
shown
three
peptid
sequenc
identifi
shown
design
h
f
respect
parenthesi
fig
bind
peptid
papn
bind
abil
identifi
peptid
papn
investig
elisa
coat
papn
target
protein
tge
virion
ibv
protein
produc
express
system
use
posit
neg
control
respect
od
valu
shown
axi
dyson
murray
adenoviru
type
hong
boulang
and
viru
andv
hall
et
al
sin
nombr
viru
hantaan
viru
larson
et
al
studi
immobil
papn
use
target
incub
phage
phage
display
librari
bind
phage
elut
four
round
pan
increas
bind
abil
phage
papn
indic
gradual
increas
phage
titrat
follow
pan
three
peptid
sequenc
obtain
ten
select
phage
bind
peptid
papn
protein
somewhat
lower
bind
papn
tgev
although
much
higher
control
indic
epitop
tgev
necessari
interact
virion
papn
sinc
peptid
react
ibv
protein
express
system
phage
crossreact
histag
protein
plaqu
assay
show
infect
tgev
nativ
papnexpress
st
cell
decreas
pretreat
individu
peptid
slight
differ
abil
peptid
inhibit
tgev
infect
interestingli
antivir
abil
three
peptid
posit
correl
bind
abil
papn
studi
mtt
assay
confirm
inhibitori
effect
peptid
tgev
infect
nonetheless
prolifer
rate
infect
cell
lower
mockinfect
cell
although
improv
pretreat
peptid
discrep
result
plaqu
assay
mtt
assay
may
partial
attribut
latter
often
use
determin
mitochondri
dehydrogenas
activ
cell
reflect
inhibit
cell
death
cell
respir
total
cell
apoptosi
induc
tgev
may
interfer
mtt
result
certain
extent
eleouet
et
al
document
four
major
antigen
site
tgev
locat
ntermin
half
protein
design
studi
sequenc
align
peptid
tgev
protein
indic
three
peptid
homolog
ident
differ
region
protein
suppos
peptid
sequenc
counterpart
protein
import
receptor
bind
domain
rbd
may
interact
cellular
receptor
papn
bind
tgev
protein
papn
requir
initi
stage
infect
delma
et
al
interact
peptid
papn
investig
use
elisa
viru
plaqu
assay
interestingli
peptid
show
effect
bind
papn
inhibit
tgev
infect
although
sequenc
complet
ident
homolog
region
protein
result
confirm
short
peptid
combinatori
librari
act
surrog
ligand
protein
interact
protein
possess
requir
critic
residu
geysen
et
al
ruoslahti
pierschbach
well
peptid
use
lead
compound
optim
consequ
enhanc
antivir
activ
addit
bind
papn
tgev
virion
treat
neuraminidas
bind
via
protein
nacetyl
neuramin
acid
nglycolyl
neuramin
acid
moieti
cell
surfac
krempl
et
al
schultz
et
al
propos
bind
surfac
sialoglycoprotein
requir
tgev
primari
attach
site
initi
infect
intestin
cell
schwegmannwessel
et
al
therefor
would
interest
screen
ligand
sialoglycoprotein
analyz
role
context
tgev
infect
structur
data
limit
function
inform
regard
spike
glycoprotein
coronavirus
serogroup
includ
tgev
fcov
ccov
although
use
apn
receptor
enter
cell
benbac
et
al
bonavia
et
al
delma
et
al
hegyi
kolb
yeager
et
al
therefor
peptid
identifi
studi
high
homolog
region
protein
could
major
rbd
viral
protein
peptid
also
expect
viabl
altern
peptidebas
drug
antibodi
prevent
tgev
infect
addit
bind
domain
protein
receptor
map
start
amino
acid
shown
correspond
domain
recogn
neutral
antibodi
godet
et
al
studi
identifi
txxf
phage
display
four
txxf
motif
found
domain
interestingli
three
motif
also
exist
part
protein
work
done
analyz
biolog
role
identifi
motif
protein
phage
bear
specif
peptid
trigger
antibodi
respons
tgev
mice
immun
peptidebear
phage
sera
isol
anim
indic
time
point
use
primari
antibodi
detect
tgev
coat
elisa
plate
mockimmun
mice
mice
immun
phage
random
peptid
librari
use
control
od
valu
shown
europ
appear
porcin
respiratori
coronaviru
prcv
respiratori
mutant
tgev
decreas
risk
tge
extent
neutral
antibodi
elicit
avirul
prcv
provid
crossprotect
tgev
infect
nevertheless
tge
preval
often
report
tgev
isol
differ
region
china
indic
tgev
infect
still
threaten
chines
pig
industri
ao
et
al
bai
current
vaccin
major
prophylaxi
measur
tgev
infect
mani
studi
provid
direct
indirect
evid
involv
protein
induc
protect
immun
respons
viral
pathogen
daniel
talbot
torr
et
al
krempl
et
al
wang
et
al
tgev
protein
deriv
acidlong
precursor
polypeptid
signal
peptid
remov
protein
induc
antibodi
neutral
absenc
complement
godet
et
al
et
al
pulford
britton
et
al
investig
antigen
structur
led
identif
four
five
major
group
bcell
depend
epitop
locat
part
polypeptid
chain
delma
et
al
gebauer
et
al
enjuan
et
al
godet
et
al
anoth
signific
achiev
work
demonstr
identifi
phage
bear
specif
peptid
ntermin
region
major
coat
protein
pviii
may
induc
specif
humor
immun
respons
enhanc
cellmed
immun
serum
antibodi
immun
mice
react
tge
virion
indic
phage
display
specif
peptid
mimic
natur
epitop
protein
studi
includ
mix
phage
phage
librari
control
immun
mice
bind
assay
rel
high
background
observ
tgev
unrelev
phage
one
hand
specul
tgev
ligand
librari
identifi
hand
heterolog
gene
express
pviii
phage
might
possibl
compon
phage
may
bind
activ
tgev
work
need
confirm
hypothes
number
lymphocyt
spleen
peripher
blood
immun
mice
increas
day
postimmun
find
interest
seem
phage
bear
heterolog
peptid
may
stimul
lymphocytemedi
immun
respons
phagebas
vaccin
use
excel
heterolog
antigen
recogn
specif
antigenpres
cell
initi
host
immun
respons
sinc
global
abund
phage
increas
abil
exploit
elucid
mechan
phagemedi
immun
may
facilit
ration
design
novel
phagebas
vaccin
addit
compar
peptidebas
vaccin
phagebas
vaccin
own
advantag
product
cost
effici
conclus
obtain
peptid
sequenc
recogn
papn
protein
use
phage
display
librari
chemic
synthes
peptid
block
cell
infect
tgev
competit
bind
viral
cellular
receptor
put
rbd
local
sequenc
align
peptid
tgev
protein
sinc
mani
coronavirus
group
use
apn
receptor
peptid
select
studi
may
candid
molecul
inhibitor
phage
bear
specif
peptid
may
elicit
humor
cellular
immun
respons
indic
present
methodolog
potenti
develop
novel
phagebas
novel
vaccin
recombin
plasmid
contain
fulllength
papn
gift
dr
georg
herrler
institut
virolog
univers
veterinari
medicin
hannov
germani
use
templat
pcr
amplifi
truncat
papn
gene
start
amino
acid
use
sens
primer
ggggggatccgagaagaacaagaatgcc
antisens
primer
ccccctcgagtgctgtgctctatgaacca
underscor
part
contain
bamhi
xhoi
restrict
site
respect
pcr
profil
includ
min
cycl
min
min
final
fig
chang
lymphocyt
peripher
blood
spleen
immun
mice
lymphocyt
peripher
blood
spleen
immun
mice
isol
number
cell
subset
quantifi
flow
cytometri
number
cell
peripher
blood
shown
b
respect
number
cell
spleen
shown
c
respect
extens
min
purifi
pcr
product
insert
site
vector
convent
clone
techniqu
result
recombin
plasmid
design
petapn
petapn
transform
e
coli
strain
plyss
novagen
germani
express
gene
interest
induc
isopropyl
iptg
final
concentr
mm
bacteri
express
protein
identifi
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
purifi
gelpurif
method
use
gener
rabbit
antipapn
antibodi
previous
describ
liu
et
al
transmiss
gastroenter
viru
tgev
purdu
strain
gift
dr
lui
enjuan
centro
nacion
de
csic
madrid
spain
use
viru
infect
assay
analyz
blockad
antipapn
antibodi
tgev
infect
st
cell
plate
incub
antibodi
achiev
studi
h
complet
wash
tgev
moi
multipl
infect
use
infect
cell
h
cell
wash
three
time
pb
inoculum
replac
wv
methylcellulos
emem
mlwell
follow
incub
h
unrel
control
rabbit
sera
includ
control
well
subject
virusplaqu
reduct
assay
use
crystal
violet
stain
ren
et
al
purifi
papn
use
target
protein
subject
biopan
use
phage
display
peptid
librari
kit
procedur
perform
accord
manufactur
instruct
modif
new
england
biolab
usa
briefli
protein
interest
concentr
nahco
ph
buffer
coat
onto
plate
overnight
plate
block
h
pb
contain
bsa
follow
six
time
wash
tbst
mm
trishcl
ph
mm
nacl
volvol
tween
phage
librari
dilut
tbst
ad
plate
final
concentr
pfu
ml
room
temperatur
min
gentl
rock
unbound
phage
remov
time
wash
tbst
bound
phage
elut
use
elut
buffer
glycinehcl
ph
eluat
neutral
trishcl
ph
amplifi
e
coli
bacteria
phage
purifi
polyethylen
glycol
precipit
accord
manufactur
instruct
four
round
pan
perform
phage
concentr
elut
buffer
amplif
host
cell
titter
papn
protein
coat
onto
elisa
plate
well
parallel
bsa
use
control
follow
day
plate
block
h
room
temperatur
tbsb
mm
trishcl
ph
mm
nacl
bsa
room
temperatur
h
plate
incub
select
phage
unrelev
control
phage
concentr
pfuwel
h
tbst
wash
subsequ
polyclon
antibodi
abcam
dilut
tbsb
ad
well
anoth
h
wash
six
time
tbst
well
incub
hrpconjug
antirabbit
igg
antibodi
sigma
dilut
color
develop
use
ophenylenediamin
opd
optic
densiti
od
valu
read
use
elisa
reader
wavelength
nm
experi
perform
triplic
ten
posit
phage
clone
amplifi
precipit
polyethylen
glycolnacl
dna
individu
phage
purifi
plasmid
extract
kit
nanj
keygen
biotech
co
ltd
china
gene
encod
exogen
peptid
amplifi
dna
templat
use
primer
sens
primer
antisens
primer
pcr
product
sequenc
deduc
amino
acid
sequenc
compar
transmiss
gastroenter
viru
tgev
protein
genbank
access
number
peptid
deriv
biopan
synthes
tianma
peptid
engin
compani
suzhou
china
individu
peptid
dilut
nahco
ph
buffer
final
concentr
purifi
tgev
infecti
bronchiti
viru
ibv
protein
concentr
use
control
protein
coat
elisa
plate
overnight
purifi
papn
protein
ad
well
h
rins
well
incub
antipapn
antibodi
dilut
anoth
h
well
incub
hrpconjug
goat
antirabbit
igg
antibodi
room
temperatur
h
complet
wash
elisa
result
record
wavelength
nm
nontox
concentr
peptid
cell
determin
use
trypan
blue
stain
mtt
tetrazolium
bromid
assay
sui
et
al
st
cell
plate
incub
serial
dilut
peptid
h
cell
wash
three
time
pb
infect
tgev
moi
h
cell
overlaid
wv
serumfre
dmem
methylcellulos
subject
plaqu
analysi
mock
treat
viru
infect
cell
use
control
st
cell
plate
incub
serial
dilut
peptid
h
tgev
moi
use
infect
cell
h
subsequ
well
wash
three
time
pb
mtt
mgml
ad
well
h
supernat
discard
dimethyl
sulfoxid
ad
well
min
gentl
shake
od
well
determin
use
plate
reader
parallel
mockinfect
virusinfect
cell
includ
control
healthi
kunm
mice
week
age
purchas
harbin
veterinari
research
institut
china
mice
divid
five
group
micegroup
mockimmun
group
phage
express
f
peptid
group
f
phage
express
peptid
group
phage
express
h
peptid
group
h
mix
phage
phage
librari
use
control
first
vaccin
peptideexpress
phage
titer
pfuml
mix
equal
volum
freund
complet
adjuv
immunogen
inject
mice
intramuscularli
ten
day
later
mice
receiv
antigen
mix
equal
volum
freund
incomplet
adjuv
ten
day
later
mice
inject
phage
alon
day
postimmun
lymphocyt
peripher
blood
collect
eye
arteri
spleen
immun
mice
micegroup
isol
lymphocyt
separ
solut
invitrogen
usa
accord
manufactur
instruct
cell
suspend
pb
densiti
cellsml
cell
sampl
centrifug
g
min
wash
two
time
cold
pb
incub
fitcconjug
cell
antibodi
zhongshan
china
peconjug
cell
antibodi
zhongshan
china
min
antibodi
dilut
pb
cell
wash
resuspend
pb
subject
flow
cytometri
analysi
time
tge
virion
coat
elisa
plate
serum
isol
immun
mice
use
primari
antibodi
follow
incub
hrpconjug
second
antibodi
day
postimmun
od
valu
read
use
elisa
plate
reader
data
analyz
use
student
ttest
express
mean
valu
standard
error
mean
sem
p
valu
b
consid
statist
signific
